Tumefactive demyelination of the spinal cord: a case report

Spinal Cord. 2015 Dec;53(12):877-80. doi: 10.1038/sc.2015.52. Epub 2015 Jun 30.

Abstract

Study design: Case report.

Objectives: We report on a 52-year-old male patient with tumefactive demyelination of the spinal cord.

Setting: University Hospital and Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.

Background: In contrast to relatively frequent tumefactive fulminant lesions in the brain, cases affecting the spinal cord in isolation have been reported less frequently.

Methods: Description of the case report.

Results: Clinical, neuroradiological and necropsy findings are described in a 52-year-old man with tumefactive fulminant demyelination of the spinal cord. Progression of the demyelination process produced paraplegia, mild paresis of the right upper limb, neurogenic bladder and sensitive loss over 2 weeks. MRI scans revealed several ovoid lesions in cervical segments and tumefactive T2-hyperintense signals with oedema and post-contrast enhancement located in thoracic segments Th3 to Th6. Cerebrospinal fluid (CSF) examination displayed lymphomonocytic pleocytosis with normal proteinorhachia, positive CSF oligoclonal IgG bands (OCB) and elevated IgG index (1.55). Serum anti-AQP4-Ab was not tested. Stored frozen CSF samples were later repeatedly examined with negative findings of anti-AQP4-Ab. Treatment with high-dose methylprednisolon and plasma exchange had limited effect. Immunosuppressive medication was interrupted because of an acute urinary infection. The patient died suddenly because of pulmonary embolism as a secondary complication. Histopathology of the spinal cord confirmed active demyelination. We considered that tumefactive demyelination could be a variant of neuromyelitis optica.

Conclusion: Our case could be anti-AQP4-Ab-negative longitudinally extensive transverse myelitis, a variant of neuromyelitis optica.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aquaporin 4 / immunology
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Myelitis, Transverse / cerebrospinal fluid
  • Myelitis, Transverse / complications*
  • Myelitis, Transverse / pathology
  • Myelitis, Transverse / therapy
  • Neuroprotective Agents / therapeutic use
  • Oligoclonal Bands / cerebrospinal fluid
  • Plasma Exchange
  • Spinal Cord / pathology
  • Spinal Cord Injuries / cerebrospinal fluid
  • Spinal Cord Injuries / complications*
  • Spinal Cord Injuries / pathology
  • Spinal Cord Injuries / therapy

Substances

  • Aquaporin 4
  • Neuroprotective Agents
  • Oligoclonal Bands
  • Methylprednisolone